Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Inhibrx Biosciences Insider Bought Shares Worth $500,000, According to a Recent SEC Filing

Inhibrx Biosciences Insider Bought Shares Worth $500,000, According to a Recent SEC Filing

MT newswireMT newswire2026/09/23 21:01
05:01 PM EDT, 09/23/2026 (MT Newswires) -- Jon Faiz Kayyem, Director, on September 23, 2026, executed a purchase for 5,000 shares in Inhibrx Biosciences (INBX) for $500,000. Following the Form 4 filing with the SEC, Kayyem has control over a total of 1,074,046 common shares of the company, with 1,074,046 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/2007919/000136626826000011/xslF345X05/wk-form4_1790197155.xml
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!